A detailed history of Susquehanna International Group Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Susquehanna International Group Ltd. holds 1,021 shares of LLY stock, worth $763,718. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,021
Holding current value
$763,718
% of portfolio
0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $788,354 - $980,180
1,021 New
1,021 $904,000
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $1.21 Million - $1.62 Million
2,045 New
2,045 $1.59 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Susquehanna International Group Ltd. Portfolio

Follow Susquehanna International Group Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group Ltd. with notifications on news.